Funded Startups in Minhang
Among the 6 most recent Minhang-funded entries, the largest disclosed round is YolTech Therapeutics’ $42M Series B on 2025-09-14; the next-highest disclose…
Among the 6 most recent Minhang-funded entries, the largest disclosed round is YolTech Therapeutics’ $42M Series B on 2025-09-14; the next-highest disclosed amount is Waker Biology’s $14M Series A on 2025-11-26, so the top disclosed deal is a clear outlier above the rest of the disclosed figures. At the other end, the smallest disclosed amount is $14M (Waker Biology, 2025-11-26), while the majority of rows list “undisclosed” amounts (4 of 6).
Timing and stage also cluster tightly: round dates span 2025-09-14 to 2025-11-26, with two filings in November (Waker Biology on 11-26 and Ruiyi Medical on 11-21) and a dense late-September to mid-November run (Volant Aerotech on 10-01 and Corerong Technology on 11-08). Sector coverage is fragmented across areas like healthcare, aerospace/automotive, and biotech, and the stage mix skews toward Series A and Series B (4 of 6 are Series A or Series B), with one Seed (Corerong Technology).
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in Minhang here, and how does it compare with other disclosed amounts?
YolTech Therapeutics’ $42M Series B (2025-09-14) is the largest disclosed amount, and it stands well above the next disclosed figure: Waker Biology’s $14M Series A (2025-11-26). The remaining disclosed amount is not reported separately beyond those entries; 4 of 6 rows are “undisclosed.”
Do these rounds cluster in a narrow time window rather than spreading across months or years?
Yes. The 6 shown rounds run from 2025-09-14 (YolTech Therapeutics) to 2025-11-26 (Waker Biology), with multiple November closings (2025-11-26, 2025-11-21, 2025-11-17, 2025-11-08) and only one disclosed amount in late September/early October (Volant Aerotech on 2025-10-01, undisclosed).
Which entries have undisclosed vs. disclosed round sizes, and does that affect any “largest/smallest” conclusions?
4 of the 6 rows are “undisclosed” in amount (Ruiyi Medical 2025-11-21, Qiaotian Intelligent 2025-11-17, Corerong Technology 2025-11-08, Volant Aerotech 2025-10-01). That makes disclosed comparisons hinge mainly on YolTech Therapeutics ($42M on 2025-09-14) and Waker Biology ($14M on 2025-11-26).
How does the stage mix look across this Minhang snapshot?
Series A and Series B dominate: Waker Biology (Series A, 2025-11-26, $14M), Ruiyi Medical (Series A, 2025-11-21, undisclosed), Qiaotian Intelligent (Series A, 2025-11-17, undisclosed), and YolTech Therapeutics (Series B, 2025-09-14, $42M) total 4 of 6 entries. Corerong Technology is the single Seed (2025-11-08, undisclosed), and Volant Aerotech is the other Series B (2025-10-01, undisclosed).
Are there sector clusters or notable outliers in what’s represented?
There’s no single sector that appears in 3+ entries; the list is fragmented across healthcare (Waker Biology and Ruiyi Medical), manufacturing/robotics (Qiaotian Intelligent and Corerong Technology), and aerospace/automotive (Volant Aerotech and Corerong Technology). The most pronounced outlier is the gaming angle in YolTech Therapeutics (Series B, $42M on 2025-09-14) versus the otherwise more industrial/healthcare-centric profiles.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.